Search

everythinglearnresearchcommunity

for

Search:↓

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

Early onset hair loss linked to genetics and androgen levels.

Finasteride reduces corpus cavernosum weight but doesn't affect erectile response in rats.

Hair loss may indicate higher heart risk and metabolic issues.

A higher testosterone to dihydrotestosterone ratio may indicate worse metabolic health in women.

Men with certain types of baldness at age 45 may have a higher risk of colon cancer and colorectal adenoma.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Cocaine impairs male sexual behavior and alters testosterone metabolism in the brain.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

The document concludes that current treatments for androgenic alopecia are not fully effective, but new therapies like botulinum toxin and PRP show promise, and future gene therapy could be beneficial.

Genetic and environmental factors, like smoking and exercise, affect male hair loss.

Male hormones worsen kidney transplant damage, but blocking them helps.

Cosmetic hair treatments can increase hair testosterone levels, while natural hair color does not affect it.

Hair cortisol can measure chronic stress but has inconsistent results.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Finasteride safely and effectively treats male pattern hair loss, but may cause reversible sexual issues and harm male fetuses.

Photobiomodulation therapy using red and near-infrared light can reduce inflammation and aid in healing various conditions.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.